TESAMORELIN and CJC 1295 are classified as synthetic GHRH analogs, belonging to the broader category of peptide therapies
IGF-1 LR3 Regulatory Status United States (as of June 2026)
While oral formulations are beginning to enter the market, so far they remain less effective and more expensive to manufacture
In the oral cavity, LL-37 (a cathelicidin), histatins (salivary peptides), and human beta-defensins (HBDs) are produced continuously but their expression is suppressed by chronic inflammation, poor nutrition, and aging, contributing to periodontal disease progression
They can offer personalized guidance based on your medical history and how you have tolerated the medication so far
10.12998/wjcc.v10.i18.5934 23 IssaianA.HayA.DzieciatkowskaM.RobertiD.PerrottaS.DarulaZ.et al (2020)